Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term G0.10 does not refer to a known therapeutic target molecule or receptor in biological or pharmaceutical research. In scientific literature, this alphanumeric string most frequently appears as a typographical artifact resulting from the misreading of the plus-minus symbol (±) in statistical data (e.g., mean ± 0.10 appearing as G0.10). It is also used in nanotechnology to describe a range of dendrimer generations (G0 through G10), which are synthetic branched polymers used for drug delivery rather than serving as targets themselves. Additionally, G0 refers to the quiescent phase of the cell cycle, and G0.10-0.08 is the name of an astronomical molecular cloud. There is no evidence of a protein, enzyme, or receptor canonically named G0.10.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G0.10.